INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,664 | +19.7% | 343,110 | 0.0% | 0.12% | +26.9% |
| Q2 2023 | $7,240 | +23.8% | 343,110 | 0.0% | 0.09% | +16.2% |
| Q1 2023 | $5,850 | -14.7% | 343,110 | 0.0% | 0.08% | -12.1% |
| Q4 2022 | $6,855 | -99.9% | 343,110 | 0.0% | 0.09% | -10.8% |
| Q3 2022 | $7,391,000 | +9.2% | 343,110 | 0.0% | 0.10% | +20.0% |
| Q2 2022 | $6,766,000 | -16.1% | 343,110 | 0.0% | 0.08% | -3.4% |
| Q1 2022 | $8,063,000 | -13.7% | 343,110 | 0.0% | 0.09% | 0.0% |
| Q4 2021 | $9,346,000 | -1.1% | 343,110 | 0.0% | 0.09% | -9.3% |
| Q3 2021 | $9,449,000 | -3.2% | 343,110 | 0.0% | 0.10% | -4.0% |
| Q2 2021 | $9,765,000 | -16.4% | 343,110 | 0.0% | 0.10% | -11.4% |
| Q1 2021 | $11,686,000 | -8.4% | 343,110 | -10.4% | 0.11% | -10.9% |
| Q4 2020 | $12,754,000 | -10.4% | 383,110 | -13.5% | 0.13% | -20.0% |
| Q3 2020 | $14,242,000 | +16.7% | 443,110 | 0.0% | 0.16% | +12.7% |
| Q2 2020 | $12,203,000 | +71.8% | 443,110 | 0.0% | 0.14% | +43.4% |
| Q1 2020 | $7,103,000 | -32.9% | 443,110 | 0.0% | 0.10% | -21.4% |
| Q4 2019 | $10,581,000 | +35.4% | 443,110 | 0.0% | 0.13% | +27.3% |
| Q3 2019 | $7,816,000 | -22.3% | 443,110 | +12.7% | 0.10% | -20.8% |
| Q2 2019 | $10,064,000 | +206.1% | 393,110 | +247.5% | 0.12% | +197.6% |
| Q1 2019 | $3,288,000 | +121.6% | 113,110 | 0.0% | 0.04% | +100.0% |
| Q4 2018 | $1,484,000 | -69.5% | 113,110 | -53.0% | 0.02% | -66.1% |
| Q3 2018 | $4,866,000 | -49.9% | 240,642 | -41.4% | 0.06% | -54.1% |
| Q2 2018 | $9,719,000 | +15.8% | 410,954 | +10.3% | 0.14% | +4.7% |
| Q1 2018 | $8,392,000 | -31.3% | 372,662 | -4.9% | 0.13% | -27.1% |
| Q4 2017 | $12,223,000 | -12.5% | 392,007 | -12.4% | 0.18% | -10.6% |
| Q3 2017 | $13,964,000 | +475.1% | 447,429 | +216.3% | 0.20% | +435.1% |
| Q2 2017 | $2,428,000 | +13.2% | 141,471 | +15.5% | 0.04% | +2.8% |
| Q1 2017 | $2,144,000 | – | 122,450 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |